Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.33 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.33 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.33 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.33 |
| ▸ | LTA4H | P09960 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5430516 | 0.78 | TSHR (0.32) | TSHRORAI1ORAI2ORAI3TRPV6 | |
| SCHEMBL8405513 | 0.78 | CA4 (0.38) | TSHRORAI1ORAI2ORAI3TRPV6 | |
| SCHEMBL11415511 | 0.76 | LTA4H (0.39) | TSHRLTA4HALDH1A1 | |
| SCHEMBL23701035 | 0.72 | NPSR1 (0.35) | TSHRLTA4HALDH1A1 | |
| SCHEMBL297217 | 0.71 | TSHR (0.39) | TSHRORAI1ORAI2ORAI3TRPV6 | |
| SCHEMBL203456 | 0.71 | — | — | |
| SCHEMBL28882615 | 0.71 | — | — | |
| SCHEMBL11293210 | 0.69 | TSHR (0.37) | TSHRORAI1ORAI2ORAI3TRPV6 | |
| Water SCHEMBL9174447 | 0.69 | TSHR (0.37) | TSHRORAI1ORAI2ORAI3TRPV6 | |
| SCHEMBL22830125 | 0.69 | TSHR (0.37) | TSHRORAI1ORAI2ORAI3TRPV6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1719794-B1 | NOVEL POLYMERS AND USES THEREOF | MITSUI CHEMICALS INC (JP) | 2017-01-04 | — | — | EP | disclosed |
| US-7977429-B2 | Polymers and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2011-07-12 | — | — | US | disclosed |
| EP-1428795-B1 | SILSESQUIOXANE DERIVATIVES AND PROCESS FOR PRODUCTION THEREOF | CHISSO CORP (JP) | 2009-07-22 | — | — | EP | disclosed |
| US-7449539-B2 | Silsesquioxane derivative and production process for the same | CHISSO CORPORATION (JP) | 2008-11-11 | — | — | US | disclosed |
| US-20070154431-A1 | Novel polymers and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2007-07-05 | — | — | US | disclosed |
| US-20070032454-A1 | Silsesquioxane derivative and production process for the same | JNC CORPORATION (JP) | 2007-02-08 | — | — | US | disclosed |
| US-7169873-B2 | Silsesquioxane derivatives and process for production thereof | CHISSO CORPORATION (JP) | 2007-01-30 | — | — | US | disclosed |
| EP-1719794-A1 | NOVEL POLYMERS AND USES THEREOF | Mitsui Takeda Chemicals, Inc. (JP) | 2006-11-08 | — | — | EP | disclosed |
| US-20040249103-A1 | Silsesquioxane derivatives and process for production thereof | JNC CORPORATION (JP) | 2004-12-09 | — | — | US | disclosed |
| EP-1428795-A1 | SILSESQUIOXANE DERIVATIVES AND PROCESS FOR PRODUCTION THEREOF | CHISSO CORPORATION (JP) | 2004-06-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070154431-A1 | Novel polymers and uses thereof | RAD54L, VCL, TYR | TSHR 2262/4885ORAI1 3384/4885ORAI2 3828/4885 |
| US-20070032454-A1 | Silsesquioxane derivative and production process for the same | KCNQ1, KCNQ2, KCNQ5 | TSHR 4266/4885ORAI1 1165/4885ORAI2 1027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.